Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "sandoz inc"

Atlantic Information Services Webinar to Discuss Payer Strategies for the U.S. Biosimilars Market
Broadway World

FDA Approves First Biosimilar; Experts Give Payers Advice on H...

PRWeb The Food and Drug Administration (FDA) issued its first approval for a biosimilar product, Sandoz Inc.'s Zarxio (filgrastim-sndz), earlier this month, and the pharmaceutical industry is expecting more approvals to come: the agency granted the ... RCL Advisors, 1 month ago
Hurdles Remain For Biosimilars—Including Savings Pharmacy Practice News, 1 week ago
[x]  

5 images for sandoz inc

Maryland Gazette, 1 week ago
NewsReality.com, 1 month ago
Livemint.com, 3 months ago
Talk Radio News Service, 6 months ago
Reuters UK, 6 months ago
Nasdaq

Momenta announces FDA approval for Sandoz's multiple sclerosis drug

Momenta Pharmaceuticals, Inc., a biotechnology company, has announced that the FDA has granted marketing approval for Sandoz's abbreviated new drug application, or ANDA, for Glatopa 20mg/mL, a once daily, generic equivalent of COPAXONE 20mg, ...
 Individual.com4 days ago Momenta Pharmaceuticals, Inc. Presents Key Glatopa (Glatiramer Acetate Injection) Data At American Academy of Neurology Annual Meeting  BioSpace1 week ago Momenta Presents Key Glatopa(TM) (glatiramer acetate injection) Data at American Academy of Neurology Annual Meeting  A.M. Best1 week ago Momenta Pharmaceuticals Inc. (MNTA) in Focus: Stock Jumps 6.1% - Tale of the Tape  Zacks.com1 week ago
[x]  
Food Consumer

FDA Approves Generic Multiple-Sclerosis Drug by Novartis's Sandoz and Momenta -- Update

The generic, known as Glatopa, was developed by Novartis AG's Sandoz business and Momenta Pharmaceuticals Inc. Sandoz is evaluating the timing of the launch, Momenta said in a news release. Shares of Momenta jumped 6.1% Thursday to $17.08.
 Morningstar.com1 week ago FDA approves first generic version of Teva's MS drug Copaxone  CNBC1 week ago FDA Approves Novartis and Momenta's Generic Multiple-Sclerosis Drug  Morningstar.com1 week ago UPDATE 1-FDA approves first generic version of Teva MS drug Copaxone  CNBC1 week ago
[x]  
Channel NewsAsia

Amgen Inc. v. Sandoz Inc.

, the United States District Court for the Northern District of California issued its decision in , construing the patent negotiation provisions of the Biologics Price Competition and Innovation Act (BPCIA). The court ruled that the BPCIA's patent ...
 JD Supra3 weeks ago Amgen v. Sandoz Update -- BIO Files an Amicus Brief at the Federal Circuit  JD Supra5 days ago Dancing Not Required: District Court Denies Amgen's Bid for Preliminary Injunction, Finds BPCIA Patent Dance Optional  JD Supra1 month ago California Federal Judge Finds Biosimilar Patent Procedures Optional  National Law Review1 month ago
[x]  

Judge rejects Amgen request to block Sandoz's copycat drug

A federal judge rejected Amgen Inc.'s effort to temporarily block a competitor from releasing a copycat version of one of its top-selling biologic drugs. The Thousand Oaks biotech company had accused Novartis subsidiary Sandoz of violating the ...
 Los Angeles Times1 month ago Judge Denies Amgen's Request to Block Novartis's Biosimilar of Neupogen  Investors Hub1 month ago Novartis : Judge Denies Amgen's Request to Block Novartis's Biosimilar of Neupogen  4 Traders1 month ago Judge Denies Amgen''s Request to Block Novartis''s Biosimilar of Neupogen  Nasdaq1 month ago
[x]  
JD Supra

Teva Pharms USA, Inc. v. Sandoz, Inc.

Spring 2015 Case Name: , No. 10-13-854, 135 S. Ct. 831 (Mar. 20, 2012) (Breyer, J. delivered opinion of the Court, in which Roberts, C.J., and Scalia, Kennedy, Ginsburg, Sotomayor, and Kagan, JJ., joined; Thomas, J., filed a dissenting opinion, ...
 JD Supra1 week ago Spotlight on extrinsic evidence  Intellectual Property Magazine1 week ago Where Do We Go from Here? Teva's Impact on IPR and District Court Practice  JD Supra2 weeks ago Did Teva Alter the Standard for Invalidating a Patent for Indefiniteness?  National Law Review1 month ago
[x]  

InSite Vision Inc. v. Sandoz, Inc. (Fed. Cir. 2015)

The Federal Circuit showed once again the importance of a district court's factual findings (and the deference the appellate court gives those findings, particularly when supported by expert testimony), in InSite Vision Inc. v. Sandoz, Inc. In last ...
 JD Supra1 week ago VASUDEVAN SOFTWARE INC v. MICROSTRATEGY INC TIBCO  Find Law2 weeks ago APOTEX INC v. DAIICHI SANKYO INC  Find Law3 weeks ago

Alert - Biologics Price Competition and Innovation Act (BPCIA) Developments

The Evolving World of Biosimilars Amgen, Inc. v. Sandoz, Inc. Addressing two new issues in the Biologics Price Competition and Innovation Act (BPCIA), the Northern District of California issued an order, on summary judgment, dismissing ...
 JD Supra1 month ago Patent Strategy Implications in the Biosimilars Space  Pharmaceutical Executive1 week ago

Sandoz Pays US$12.6M to Settle False Drug Pricing Allegations

Sandoz Inc. will pay US$12.6 million wto settle allegations it misrepresented drug pricing data to the Medicare programme. The deal, which includes no admission of wrongdoing, centers on so-called average sales prices used to determine payment for ...
 PharmaAsia1 month ago Sandoz to Pay $12.64 Million in CMP Settlement with HHS OIG for Misrepresenting Drug Pricing Data to Medicare  FiercePharma1 month ago

NOVARTIS : CONTRACT AWARD - 65-- Nadolol Tablets Sandoz, Inc. Effective: 7/1/2015 - 6/30/2015 Plus 4 One Year Option Periods

Notice Type: CONTRACT AWARD Posted Date: 27-FEB-15 Office: VA National Acquisition Center Location: DEPARTMENT OF VETERANS AFFAIRS NATIONAL ACQUISITION CENTER Office Address: DEPARTMENT OF VETERANS AFFAIRS , VA NATIONAL ACQUISITION ...
 4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less